These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8102766)

  • 1. Immunoreactive dynorphin A-like material in extracted human hypothalamic-hypophysial plasma.
    Spampinato S; Paradisi R; Canossa M; Campana G; Frank G; Flamigni C; Ferri S
    Life Sci; 1993; 52(2):223-30. PubMed ID: 8102766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of immunoreactive dynorphin B-like material in human, rat, rabbit and guinea-pig heart.
    Spampinato S; Canossa M; Ventura C; Bachetti T; Venturini R; Bastagli L; Bernardi P; Ferri S
    Life Sci; 1991; 48(6):551-9. PubMed ID: 1671525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of immunoreactive dynorphin in human phaeochromocytomas.
    Howlett TA; Besser GM; Rees LH
    J Endocrinol; 1988 Apr; 117(1):123-32. PubMed ID: 2895797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin A-(1-17) and dynorphin B are released from in vitro superfused rat hypothalami. Effects of depolarizing agents and ovariectomy.
    Spampinato S; Canossa M; Bachetti T; Campana G; Murari G; Ferri S
    Brain Res; 1992 May; 580(1-2):225-32. PubMed ID: 1354557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin-related immunoreactive peptides in rat brain and pituitary.
    Höllt V; Haarmann I; Bovermann K; Jerlicz M; Herz A
    Neurosci Lett; 1980 Jun; 18(2):149-53. PubMed ID: 7052485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hypertonic saline infusion on the level of immunoreactive dynorphin in extracted human plasma.
    Margioris AN; Brockmann G; Kalogeras KT; Fjellestad-Paulsen A; Stratakis CA; Vamvakopoulos N; Chrousos GP
    J Clin Endocrinol Metab; 1990 Aug; 71(2):298-304. PubMed ID: 1974260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive dynorphin in rat tissues and plasma.
    Spampinato S; Goldstein A
    Neuropeptides; 1983 Jan; 3(3):193-212. PubMed ID: 16229162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranslational processing of corticotropin-releasing factor in the ovine tuberoinfundibular system and pituitary.
    Smith AI; Engler D; Fullerton MJ; Pham T; Wallace C; Morgan FJ; Clarke IJ; Funder JW
    Ann N Y Acad Sci; 1987; 512():24-47. PubMed ID: 3502065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources.
    Sasaki A; Sato S; Murakami O; Go M; Inoue M; Shimizu Y; Hanew K; Andoh N; Sato I; Sasano N
    J Clin Endocrinol Metab; 1987 Jul; 65(1):176-82. PubMed ID: 3294879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal steroids and anterior lobe dynorphin in the male rat.
    Fullerton MJ; Smith AI; Clements JA; Funder JW
    J Steroid Biochem; 1989 Feb; 32(2):303-8. PubMed ID: 2564056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactive dynorphin in human brain and pituitary.
    Gramsch C; Höllt V; Pasi A; Mehraein P; Herz A
    Brain Res; 1982 Feb; 233(1):65-74. PubMed ID: 6120742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive dynorphin is regulated by estrogen in the rat anterior pituitary.
    Fullerton MJ; Smith AI; Funder JW
    Neuroendocrinology; 1988 Jan; 47(1):1-6. PubMed ID: 2893308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the ventromedial hypothalamus in the regulation of adenohypophyseal immunoreactive dynorphin in the rat.
    Spampinato S; Stanzani S; Leanza G; Russo A; Ferri S
    Brain Res; 1988 Oct; 463(1):100-6. PubMed ID: 2904293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting interactions of the locus coeruleus as compared to the ventral noradrenergic bundle with CNS and pituitary pools of vasopressin, dynorphin and related opioid peptides in the rat.
    Millan MJ; Millan MH; Członkowski A; Herz A
    Brain Res; 1984 Apr; 298(2):243-52. PubMed ID: 6144361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin peptides in human substantia nigra.
    Christensson-Nylander I; Terenius L
    Neuropeptides; 1985 Sep; 6(5):391-6. PubMed ID: 2865698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proenkephalin B (prodynorphin)-derived opioid peptides: evidence for a differential processing in lobes of the pituitary.
    Seizinger BR; Höllt V; Herz A
    Endocrinology; 1984 Aug; 115(2):662-71. PubMed ID: 6146512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of brain and pituitary pools of dynorphin as compared to vasopressin to acute stress in the rat.
    Millan MJ; Millan MH; Tsang YF; Herz A
    Life Sci; 1983; 33 Suppl 1():29-32. PubMed ID: 6141491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple forms of immunoreactive dynorphin in rat pituitary and brain.
    Suda T; Tozawa F; Tachibana S; Demura H; Shizume K
    Life Sci; 1982 Jul; 31(1):51-7. PubMed ID: 6125864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of immunoreactive dynorphin A in the human gastrointestinal tract.
    Spampinato S; Ferri GL; Candeletti S; Romualdi P; Cavicchini E; Soimero L; Labò G; Ferri S
    Neuropeptides; 1988 Apr; 11(3):101-5. PubMed ID: 2898739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypothalamic lesions on the content of dynorphin immunoreactivity in pituitary.
    Spampinato S; Candeletti S; Romualdi P; Russo A; Stanzani S; Ferri S
    Life Sci; 1983; 33 Suppl 1():503-6. PubMed ID: 6141497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.